Académique Documents
Professionnel Documents
Culture Documents
Wellesley, MA, January 21, 2021 --(PR.com)-- Charles River CFO, Inc. (CRCFO), a provider of
part-time and interim CFO and accounting services, today announced Kevin Sarney has joined the
leadership team as the Life Sciences Practice Leader and CFO. With over 20 years of experience in public
and private life sciences companies, Kevin will lead the Charles River CFO team providing strategic
CFO, accounting, and tax services.
“With the continued growth of the biotech industry in the Boston area, we are excited to have Kevin on
our team,” said Ann Vickers, CRCFO chief executive officer. “His deep experience in public biotech
companies positions us to assist in IPO readiness, fundraising, SEC reporting, financial controls, audits,
and supporting financial operations from drug development through pharmaceutical product launches.”
Kevin’s professional career began in Big 4 public accounting. He has held leadership positions at public
biotech companies and private early-stage drug development companies. Kevin has numerous
experiences in assisting companies going public at Enumeral, Tesaro, Tetraphase, Karyopharm and
Genocea.
Kevin earned a B.S. in business management from the University of Hartford, an MBA from Boston
University, and an M.A. in accounting from Suffolk University. Kevin is a CPA in Massachusetts.
“I am very excited to join Charles River CFO at this time of significant opportunity. Helping clients
strategize, analyze, and account for financial growth has always been most rewarding for me,” said
Kevin. “Joining the CRCFO team allows me to build upon my previous experience and continue to
provide the highest quality client service to the companies that rely on Charles River CFO. I look forward
to making a substantial contribution to the success of the firm and its clients.”
Page 1/2
PR.com Press Release Distribution Terms of Use
Contact Information:
Charles River CFO
Martha Stone-Martin
781.431.0420
Contact via Email
www.crcfo.com
News Image:
Page 2/2
PR.com Press Release Distribution Terms of Use